179 related articles for article (PubMed ID: 12759464)
1. Retinoic acid reduces autoimmune renal injury and increases survival in NZB/W F1 mice.
Kinoshita K; Yoo BS; Nozaki Y; Sugiyama M; Ikoma S; Ohno M; Funauchi M; Kanamaru A
J Immunol; 2003 Jun; 170(11):5793-8. PubMed ID: 12759464
[TBL] [Abstract][Full Text] [Related]
2. The beneficial effects of treatment with all-trans-retinoic acid plus corticosteroid on autoimmune nephritis in NZB/WF mice.
Nozaki Y; Yamagata T; Yoo BS; Sugiyama M; Ikoma S; Kinoshita K; Funauchi M; Kanamaru A
Clin Exp Immunol; 2005 Jan; 139(1):74-83. PubMed ID: 15606616
[TBL] [Abstract][Full Text] [Related]
3. Rapamycin prevents the development of nephritis in lupus-prone NZB/W F1 mice.
Lui SL; Yung S; Tsang R; Zhang F; Chan KW; Tam S; Chan TM
Lupus; 2008 Apr; 17(4):305-13. PubMed ID: 18413412
[TBL] [Abstract][Full Text] [Related]
4. The Ox40/Ox40 Ligand Pathway Promotes Pathogenic Th Cell Responses, Plasmablast Accumulation, and Lupus Nephritis in NZB/W F1 Mice.
Sitrin J; Suto E; Wuster A; Eastham-Anderson J; Kim JM; Austin CD; Lee WP; Behrens TW
J Immunol; 2017 Aug; 199(4):1238-1249. PubMed ID: 28696253
[TBL] [Abstract][Full Text] [Related]
5. T cell cytokine imbalance towards production of IFN-gamma and IL-10 in NZB/W F1 lupus-prone mice is associated with autoantibody levels and nephritis.
Enghard P; Langnickel D; Riemekasten G
Scand J Rheumatol; 2006; 35(3):209-16. PubMed ID: 16766368
[TBL] [Abstract][Full Text] [Related]
6. Suppression of renal disease and mortality in the female NZB x NZW F1 mouse model of systemic lupus erythematosus (SLE) by chenodeoxycholic acid.
Suwannaroj S; Lagoo A; McMurray RW
Lupus; 2001; 10(8):562-7. PubMed ID: 11530998
[TBL] [Abstract][Full Text] [Related]
7. An Ig mu-heavy chain transgene inhibits systemic lupus erythematosus immunopathology in autoimmune (NZB x NZW)F1 mice.
Wellmann U; Letz M; Schneider A; Amann K; Winkler TH
Int Immunol; 2001 Dec; 13(12):1461-9. PubMed ID: 11717187
[TBL] [Abstract][Full Text] [Related]
8. Allogeneic mesenchymal stem cells do not protect NZBxNZW F1 mice from developing lupus disease.
Youd M; Blickarz C; Woodworth L; Touzjian T; Edling A; Tedstone J; Ruzek M; Tubo R; Kaplan J; Lodie T
Clin Exp Immunol; 2010 Jul; 161(1):176-86. PubMed ID: 20456409
[TBL] [Abstract][Full Text] [Related]
9. Role of the chemokine stromal cell-derived factor 1 in autoantibody production and nephritis in murine lupus.
Balabanian K; Couderc J; Bouchet-Delbos L; Amara A; Berrebi D; Foussat A; Baleux F; Portier A; Durand-Gasselin I; Coffman RL; Galanaud P; Peuchmaur M; Emilie D
J Immunol; 2003 Mar; 170(6):3392-400. PubMed ID: 12626600
[TBL] [Abstract][Full Text] [Related]
10. Retinoic acid treatment protects MRL/lpr lupus mice from the development of glomerular disease.
Pérez de Lema G; Lucio-Cazaña FJ; Molina A; Luckow B; Schmid H; de Wit C; Moreno-Manzano V; Banas B; Mampaso F; Schlöndorff D
Kidney Int; 2004 Sep; 66(3):1018-28. PubMed ID: 15327395
[TBL] [Abstract][Full Text] [Related]
11. The Systemic Activation of Programmed Death 1-PD-L1 Axis Protects Systemic Lupus Erythematosus Model from Nephritis.
Liao W; Zheng H; Wu S; Zhang Y; Wang W; Zhang Z; Zhou C; Wu H; Min J
Am J Nephrol; 2017; 46(5):371-379. PubMed ID: 29069649
[TBL] [Abstract][Full Text] [Related]
12. Treatment of lupus-prone NZB/NZW F1 mice with recombinant soluble Fc gamma receptor II (CD32).
Werwitzke S; Trick D; Sondermann P; Kamino K; Schlegelberger B; Kniesch K; Tiede A; Jacob U; Schmidt RE; Witte T
Ann Rheum Dis; 2008 Feb; 67(2):154-61. PubMed ID: 17557887
[TBL] [Abstract][Full Text] [Related]
13. CCR1 inhibition ameliorates the progression of lupus nephritis in NZB/W mice.
Bignon A; Gaudin F; Hémon P; Tharinger H; Mayol K; Walzer T; Loetscher P; Peuchmaur M; Berrebi D; Balabanian K
J Immunol; 2014 Feb; 192(3):886-96. PubMed ID: 24367031
[TBL] [Abstract][Full Text] [Related]
14. Immunologic abnormality in NZB/NZW F1 mice. Thymus-independent occurrence of B cell abnormality and requirement for T cells in the development of autoimmune disease, as evidenced by an analysis of the athymic nude individuals.
Mihara M; Ohsugi Y; Saito K; Miyai T; Togashi M; Ono S; Murakami S; Dobashi K; Hirayama F; Hamaoka T
J Immunol; 1988 Jul; 141(1):85-90. PubMed ID: 3259971
[TBL] [Abstract][Full Text] [Related]
15. Curcumin attenuates lupus nephritis upon interaction with regulatory T cells in New Zealand Black/White mice.
Lee H; Kim H; Lee G; Chung HS; Bae H
Br J Nutr; 2013 Jul; 110(1):69-76. PubMed ID: 23181951
[TBL] [Abstract][Full Text] [Related]
16. Tumor necrosis factor and IL-1 in New Zealand Black/White mice. Enhanced gene expression and acceleration of renal injury.
Brennan DC; Yui MA; Wuthrich RP; Kelley VE
J Immunol; 1989 Dec; 143(11):3470-5. PubMed ID: 2584702
[TBL] [Abstract][Full Text] [Related]
17. CD47 deficiency ameliorates autoimmune nephritis in Fas(lpr) mice by suppressing IgG autoantibody production.
Shi L; Bian Z; Chen CX; Guo YN; Lv Z; Zeng C; Liu Z; Zen K; Liu Y
J Pathol; 2015 Nov; 237(3):285-95. PubMed ID: 26095930
[TBL] [Abstract][Full Text] [Related]
18. Treatment of NZB/W F1 mice with NZW splenic T cells or with serum of mice experiencing the graft-versus-host reaction: suppression of ongoing anti-double-stranded (ds) DNA antibody formation and improvement of renal function.
Okudaira H; Terada E; Fukuda K; Ito T; Gohda A; Nomura T; Kudo K; Ogita T; Miyamoto T
Clin Immunol Immunopathol; 1984 Sep; 32(3):359-67. PubMed ID: 6331933
[TBL] [Abstract][Full Text] [Related]
19. Reduced fragmentation of apoptotic chromatin is associated with nephritis in lupus-prone (NZB x NZW)F(1) mice.
Zykova SN; Seredkina N; Benjaminsen J; Rekvig OP
Arthritis Rheum; 2008 Mar; 58(3):813-25. PubMed ID: 18311834
[TBL] [Abstract][Full Text] [Related]
20. IFN-gamma receptor deletion prevents autoantibody production and glomerulonephritis in lupus-prone (NZB x NZW)F1 mice.
Haas C; Ryffel B; Le Hir M
J Immunol; 1998 Apr; 160(8):3713-8. PubMed ID: 9558072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]